WELLINGTON MANAGEMENT GROUP LLP 13D and 13G filings for Odonate Therapeutics, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
| 2021-04-12 08:02 am Sale |
2021-03-31 | 13G | Odonate Therapeutics, Inc. ODTC |
WELLINGTON MANAGEMENT GROUP LLP | 0 0.000% |
-0 (-100.00%) |
Filing |
| 2021-02-04 11:35 am Sale |
2020-12-31 | 13G | Odonate Therapeutics, Inc. ODTC |
WELLINGTON MANAGEMENT GROUP LLP | 0 9.790% |
-0 (-7.76%) |
Filing |
| 2020-09-09 09:10 am Purchase |
2020-08-31 | 13G | Odonate Therapeutics, Inc. ODTC |
WELLINGTON MANAGEMENT GROUP LLP | 0 10.830% |
0 (+98.36%) |
Filing |